This book investigates the regulatory requirements and technical implementation standards for electronic records and electronic signatures as mandated by the United States Food and Drug Administration. Orlando López, an expert in pharmaceutical compliance and validation, provides a comprehensive breakdown of the 21 CFR Part 11 regulation. The text serves as a practical framework for organizations to navigate the intersection of digital data integrity and federal legal compliance within the life sciences industry.

Industry professionals frequently cite this work as a foundational resource for understanding FDA compliance in digital environments. Experts highlight the technical clarity of the prose, noting its utility for quality assurance teams and IT departments tasked with maintaining regulatory standards.